Clinical Trial Update: Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study [Phase 3]

View source ↗

Summary

A Phase III randomized trial evaluating neoadjuvant chemotherapy for advanced epithelial ovarian cancer is described. The current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Ovarian Carcinoma | Phase 3 | Status: UNKNOWN